| abstract |
Disclosed is a novel cannabinoid receptor inverse agonist and antagonist which can be easily prepared from a natural source. A pharmaceutical composition for treating and / or preventing cannabinoid, CB1 and CB2 receptor-related diseases, comprising an inverse agonist of cannabinoid receptor CB1 and an eicosapentaenoic acid monoglycerol which is an antagonist of cannabinoid receptor CB2. object. In addition, a composition for eating and drinking for the treatment and / or prevention of cannabinoid, CB1 and CB2 receptor-related diseases containing a fraction derived from fish oil containing the eicosapentaenoic acid monoglycerol. [Selection figure] None |